Cardiac catheterization, the gold standard for diagnosing coronary artery disease (CAD), cannot determine whether plaques in the coronary lumen are flow-limiting or likely to rupture. Risk assessment for CAD, partnered with one of several noninvasive testing options, may provide a solution.
TO VIEW THIS AND OTHER CE/CME COURSES, CLICK HERE